loading

Ligand Pharmaceuticals Inc Borsa (LGND) Ultime notizie

pulisher
Feb 12, 2026

Ligand Pharmaceuticals Announces Fourth Quarter and Full Year 2025 Financial Results Call Scheduled for February 26, 2026 - Quiver Quantitative

Feb 12, 2026
pulisher
Feb 12, 2026

Biopharma company Ligand to reveal 2025 results Feb. 26 - Stock Titan

Feb 12, 2026
pulisher
Feb 11, 2026

Impax Asset Management Group plc Sells 60,000 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Is Ligand Pharmaceuticals Incorporated in a long term uptrendWeekly Trade Review & Expert Approved Trade Ideas - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Principal Financial Group Inc. Sells 7,210 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Feb 10, 2026
pulisher
Feb 07, 2026

Trend Review: Is AMRN a cyclical or defensive stockQuarterly Trade Report & Safe Capital Investment Plans - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 06, 2026

Ranger Investment Management L.P. Has $48.77 Million Stake in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Feb 06, 2026
pulisher
Feb 05, 2026

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), AbbVie (ABBV) and Bio-Techne (TECH) - The Globe and Mail

Feb 05, 2026
pulisher
Feb 05, 2026

Ligand Pharmaceuticals (LGND) director sells $91k in stock By Investing.com - Investing.com India

Feb 05, 2026
pulisher
Feb 05, 2026

Ligand Pharmaceuticals (LGND) director sells $91k in stock - Investing.com

Feb 05, 2026
pulisher
Feb 04, 2026

Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceutica - GuruFocus

Feb 04, 2026
pulisher
Feb 04, 2026

Ligand Pharmaceuticals (LGND) Valuation Check As Partner Milestones Expand Royalty And Growth Potential - simplywall.st

Feb 04, 2026
pulisher
Feb 04, 2026

Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Yahoo Finance

Feb 04, 2026
pulisher
Feb 04, 2026

Ligand Pharmaceuticals (NASDAQ:LGND) Director John Kozarich Sells 467 Shares - MarketBeat

Feb 04, 2026
pulisher
Feb 03, 2026

LGND: New Year Program Updates - Zacks Small Cap Research

Feb 03, 2026
pulisher
Feb 03, 2026

Villere ST Denis J & Co. LLC Has $49.59 Million Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Feb 03, 2026
pulisher
Feb 02, 2026

New York State Common Retirement Fund Decreases Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Feb 02, 2026
pulisher
Feb 01, 2026

Growth Value: Whats next for Global Business Travel Group Inc stockBuy Signal & Weekly High Potential Stock Alerts - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

Earnings Update: Should you avoid IKNA stock right nowJuly 2025 Pullbacks & Technical Pattern Alert System - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

Published on: 2026-02-02 03:00:22 - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

Lisanti Capital Growth LLC Boosts Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Jan 31, 2026
pulisher
Jan 31, 2026

Surprises Report: Can TZOO weather a recessionIndex Update & Precise Swing Trade Entry Alerts - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 30, 2026

Acuitas Investments LLC Purchases 382,597 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Jan 30, 2026
pulisher
Jan 29, 2026

Whale Trades: What is the dividend yield of Ligand Pharmaceuticals IncorporatedJuly 2025 Pullbacks & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 28, 2026

Can Ligand Pharmaceuticals Incorporated outperform in the next rallyWeekly Stock Report & Entry Point Confirmation Signals - mfd.ru

Jan 28, 2026
pulisher
Jan 27, 2026

Breakout Watch: Whats the profit margin of Ligand Pharmaceuticals IncorporatedMarket Rally & AI Driven Stock Movement Reports - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 27, 2026

7,200 Shares in Ligand Pharmaceuticals Incorporated $LGND Acquired by Pier 88 Investment Partners LLC - MarketBeat

Jan 27, 2026
pulisher
Jan 26, 2026

Is Ligand Pharmaceuticals Incorporated in a bullish channelBull Run & AI Enhanced Execution Alerts - mfd.ru

Jan 26, 2026
pulisher
Jan 26, 2026

Aug Opening: Can KRUS benefit from deglobalizationJuly 2025 Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 25, 2026

Pullback Watch: Is Ligand Pharmaceuticals Incorporated a stock for growth or value investors2025 Pullback Review & Capital Efficiency Focused Ideas - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 21, 2026

Massachusetts Financial Services Co. MA Buys 202,103 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Jan 21, 2026
pulisher
Jan 21, 2026

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 21, 2026
pulisher
Jan 17, 2026

Stephens Investment Management Group LLC Sells 50,271 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Jan 17, 2026
pulisher
Jan 15, 2026

SG Americas Securities LLC Has $2.08 Million Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Jan 15, 2026
pulisher
Jan 14, 2026

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Could Be 37% Below Their Intrinsic Value Estimate - Yahoo Finance UK

Jan 14, 2026
pulisher
Jan 13, 2026

Travere, Ligand Hammered On A Surprise Delay For Their Linchpin Drug - Investor's Business Daily

Jan 13, 2026
pulisher
Jan 13, 2026

Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13 - TechStock²

Jan 13, 2026
pulisher
Jan 13, 2026

Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap DownShould You Sell? - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Patterns Watch: Can Ligand Pharmaceuticals Incorporated stock continue upward trendJuly 2025 Breakouts & Safe Capital Growth Plans - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Published on: 2026-01-13 22:28:13 - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 12, 2026

Gamble on Huge Gains with These 3 Best Biotech Stocks to Buy for 2026 - Yahoo Finance

Jan 12, 2026
pulisher
Jan 10, 2026

Can Ligand Pharmaceuticals Incorporated stock rebound after recent weaknessJuly 2025 Fed Impact & Safe Entry Zone Tips - Улправда

Jan 10, 2026
pulisher
Jan 08, 2026

Will Ligand Pharmaceuticals Incorporated stock remain a Wall Street favoriteTrade Risk Assessment & Daily Risk Controlled Trade Plans - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

What technical signals suggest for Ligand Pharmaceuticals Incorporated stockJuly 2025 EndofMonth & High Win Rate Trade Tips - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Ligand Pharmaceuticals Incorporated stock attractive for hedge fundsQuarterly Trade Report & Entry Point Confirmation Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Ligand Pharmaceuticals Incorporated stock a top momentum playExit Point & Free Long-Term Investment Growth Plans - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Ligand Pharmaceuticals Incorporated (LGDN) stock positioned for digital growth eraMarket Performance Summary & Weekly High Return Opportunities - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Ligand Pharmaceuticals Incorporated stock positioned well for digital economyJuly 2025 Snapshot & Weekly Setup with High ROI Potential - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Risk Recap: How Ligand Pharmaceuticals Incorporated stock reacts to oil pricesMarket Trend Review & Verified Stock Trade Ideas - Улправда

Jan 08, 2026
pulisher
Jan 07, 2026

Ligand Pharmaceuticals director Kozarich sells $88,532 in stock By Investing.com - Investing.com South Africa

Jan 07, 2026
pulisher
Jan 07, 2026

Book value per share of Ligand Pharmaceuticals Incorporated – OTC:LGNYZ - TradingView — Track All Markets

Jan 07, 2026
pulisher
Jan 06, 2026

Ligand Pharmaceuticals director Kozarich sells $88,532 in stock - Investing.com

Jan 06, 2026
pulisher
Jan 05, 2026

Allspring Global Investments Holdings LLC Buys 32,379 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Jan 05, 2026
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
Capitalizzazione:     |  Volume (24 ore):